Ruby Sabina
YOU?
Author Swipe
View article: BK virus kinetics and associated cystitis/urethritis symptoms after PTCy-based allogeneic hematopoietic cell transplant
BK virus kinetics and associated cystitis/urethritis symptoms after PTCy-based allogeneic hematopoietic cell transplant Open
BK virus-associated cystitis/urethritis (BK-C) is a major cause of morbidity in allogeneic hematopoietic cell transplantation (HCT) recipients. We prospectively followed weekly plasma and urine BK viral loads and associated symptoms in 169…
View article: Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation
Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation Open
High-dose posttransplantation cyclophosphamide (HD-PTCy), given at 50 mg/kg/day on days +3/+4, is a standard-of-care graft-versus-host disease (GVHD) prophylaxis for allogeneic hematopoietic cell transplantation (HCT). Our murine MHC–haplo…
View article: REMOVED: Intravenous Hyperhydration Is Not Mandatory to Prevent Post-Transplantation Cyclophosphamide (PTCy)-Induced Hemorrhagic Cystitis in Patients Receiving Mesna
REMOVED: Intravenous Hyperhydration Is Not Mandatory to Prevent Post-Transplantation Cyclophosphamide (PTCy)-Induced Hemorrhagic Cystitis in Patients Receiving Mesna Open
This abstract has been removed: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been removed at the request of the author. This abstract has been…
View article: REMOVED: It Mite Not be GVHD: Frequent Occurrence of Demodex Folliculitis Rashes after Allogeneic Hematopoietic Cell Transplantation (alloHCT)
REMOVED: It Mite Not be GVHD: Frequent Occurrence of Demodex Folliculitis Rashes after Allogeneic Hematopoietic Cell Transplantation (alloHCT) Open
This abstract has been removed: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been removed at the request of the author. This abstract has been…
View article: REMOVED: Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Mature NK/T Cell Neoplasms – Potent Graft Vs Tumor Effect Affords Remission Even with Refractory Disease
REMOVED: Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Mature NK/T Cell Neoplasms – Potent Graft Vs Tumor Effect Affords Remission Even with Refractory Disease Open
This abstract has been removed: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been removed at the request of the author. This abstract has been…
View article: REMOVED: A Case Report of Pulmonary Mucormycosis in a Patient on Immunosuppression for Chronic Gvhd
REMOVED: A Case Report of Pulmonary Mucormycosis in a Patient on Immunosuppression for Chronic Gvhd Open
This abstract has been removed: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been removed at the request of the author. This abstract has been…
View article: Safety but limited efficacy of donor lymphocyte infusion for post-transplantation cyclophosphamide-treated patients
Safety but limited efficacy of donor lymphocyte infusion for post-transplantation cyclophosphamide-treated patients Open
The therapeutic efficacy of donor lymphocyte infusions (DLIs) given after allogeneic hematopoietic cell transplantation (HCT) is limited by risk of graft-versus-host disease (GVHD). Post-transplantation cyclophosphamide (PTCy) effectively …
View article: RETRACTED: Safety but Limited Efficacy of Donor Lymphocyte Infusion for Post-Transplantation Cyclophosphamide-Treated Patients
RETRACTED: Safety but Limited Efficacy of Donor Lymphocyte Infusion for Post-Transplantation Cyclophosphamide-Treated Patients Open
The authors have requested that this preprint be removed from Research Square.